Is there any reason to stent atherosclerotic renal artery stenosis?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

10 citing papers in PubMed.

1. Decrease of glomerular filtration rate may be attributed to the microcirculation damage in renal artery stenosis.Chinese medical journal · 2015
   Article
2. Renal artery stenosis-when to screen, what to stent?Current atherosclerosis reports · 2014
   Review
3. Renal vascular structure and rarefaction.Comprehensive Physiology · 2013
   Review
4. Renoprotective effects of hepatocyte growth factor in the stenotic kidney.American journal of physiology. Renal physiology · 2013
   Article
5. Reversal of renal dysfunction by targeted administration of VEGF into the stenotic kidney: a novel potential therapeutic approach.American journal of physiology. Renal physiology · 2012
   Article
6. Medical therapy is best for atherosclerotic renal artery stenosis: Arguments for.Indian journal of nephrology · 2012
   Article
7. VEGF: Potential therapy for renal regeneration.F1000 medicine reports · 2012
   Article
8. Renovascular hypertension: screening and modern management.European heart journal · 2011
   Review
9. Renovascular disease, microcirculation, and the progression of renal injury: role of angiogenesis.American journal of physiology. Regulatory, integrative and comparative physiology · 2011
   Article
10. Angiogenic cytokines in renovascular disease: do they have potential for therapeutic use?Journal of the American Society of Hypertension : JASH
    Review

Corrections and comments

• Comment on
  Revascularization versus medical therapy for renal-artery stenosis.2009

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.